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a  b  s  t  r  a  c  t
A  proof  of principle  gas  chromatography–mass  spectrometry  method  is  presented,  in combination  with
clean up  assays,  aiming  to  improve  the  analysis  of  methyl  mycocerosate  tuberculosis  biomarkers  from
sputum. Methyl  mycocerosates  are  generated  from  the  transesteriﬁcation  of  phthiocerol  dimycocerosates
(PDIMs),  extracted  in petroleum  ether  from  sputum  of tuberculosis  suspect  patients.  When  a  high  matrix
background  is  present  in  the  sputum  extracts,  the  identiﬁcation  of  the  chromatographic  peaks  corre-
sponding  to the methyl  derivatives  of  PDIMs  analytes  may  be  hindered  by the closely  eluting  methyl
ether  of cholesterol,  usually  an  abundant  matrix  constituent  frequently  present  in sputum  samples.
The  puriﬁcation  procedures  involving  solid  phase  extraction  (SPE)  based  methods  with  both  commer-
cial  Isolute-Florisil  cartridges,  and  purpose  designed  molecularly  imprinted  polymeric  materials  (MIPs),
resulted  in cleaner  chromatograms,  while  the mycocerosates  are  still  present.  The  clean-up  performed
on  solutions  of  PDIMs  and  cholesterol  standards  in  petroleum  ether  show  that, depending  on the  solvent
mix  and  on  the type  of  SPE  used,  the  recovery  of PDIMs  is  between  64  and  70%,  whilst  most  of the  choles-
terol  is removed  from  the  system.  When  applied  to petroleum  ether  extracts  from  representative  sputum
samples,  the  clean-up  procedures  resulted  in recoveries  of  36–68%  for  PDIMs,  allowing  some  superior
detection  of  the  target  analytes.
© 2015  Published  by  Elsevier  B.V.
1. Introduction
Tuberculosis (TB) is an infectious disease that is still of increasing
concern, with higher incidence in the underdeveloped countries, it
represents a world scale problem, given the extensive international
mobility of people in the 21st century [1], and its early diagnosis
is crucial in reducing and stopping the disease from spreading [2].
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The cell envelopes of Mycobacterium tuberculosis are rich in unusual
lipids, not present in the mammalian tissue. These compounds are
therefore considered as proper mycobacterial biomarkers that can
enable the disease detection in ﬂuids from infected patients.
Gas chromatographic–mass spectrometric (GC–MS) analysis,
following the ofﬂine or online derivatization of lipids from the
mycobacterial cell membrane, has been proven to be successful
for the TB diagnosis by detecting M. tuberculosis biomarkers in
sputum [3–7]. The 10-methyl octadecanoic acid biomarker, also
known as tuberculostearic acid (TBSA), has been frequently ana-
lyzed by GC–MS in positive [3–6] and negative chemical ionization
(NCI) modes [7], but it is almost ubiquitous among the members of
mycolata class, and in other genera such as Nocardia. Furthermore,
TBSA is dispersed in the cell envelope within a range of plasma
membrane phospholipids and lipoglycans, and access to the full
http://dx.doi.org/10.1016/j.jchromb.2015.02.010
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Fig. 1. The molecular structure of phthiocerol dimycocerosates (PDIMs), prior to
thermochemolysis. The dotted lines show the sites of cleavage during the thermally
assisted hydrolysis and methylation process.
content of TBSA requires its prior hydrolytic release by compli-
cated chemical manipulations [3,4,6,7]. Direct analysis of TBSA by
GC–MS was reported [5], following thermochemolysis of aliquots
from sputum samples, but our experiments based on this procedure
[8] resulted in poor sensitivity and speciﬁcity, owing to the TBSA
ester co-elution with derivatives of other matrix compounds, such
as the methyl ester of octadecanoic acid, which is usually present
in excessive amounts in sputum.
There are other classes of lipids which can be immediately
accessible for rapid analysis, using simple solvent extraction from
culture or sputum sample deposits. Our study involves the more
accessible class, the family of phthiocerol dimycocerosates (PDIMs)
shown in Fig. 1. They are stable, high molecular weight hydropho-
bic waxes of around a 90 carbon backbone, which are highly
resistant to hydrolysis, and hence will survive the usual proce-
dures used to sterilize infected materials isolated from patients.
The mycocerosate components are only present in a limited num-
ber of mycobacteria (Mycobacterium microti,  Mycobacterium bovis,
Mycobacterium kansasii, Mycobacterium marinum, Mycobacterium
ulcerans and Mycobacterium leprae)  [9–12]. The methyl derivatives
of mycocerosates from M.  tuberculosis give characteristic doublet
peaks with dominant C29, C30, and C32 components. In an early
study by Larsson, 5-days-old cultures of sputum specimens were
shown by GC–MS to have C32 mycocerosates [6]. Negative-ion
chemical ionization GC–MS methods developed for sensitive detec-
tion of mycobacterial mycocerosates [9], has been used to detect
mycocerosate biomarkers for ancient tuberculosis in a skeletal col-
lection [13].
Our work focuses on PDIMs as excellent M.  tuberculosis biomark-
ers. Following apolar lipid extraction from sputum, PDIMs were
submitted to thermally assisted hydrolysis and methylation (THM)
in the programmed temperature vaporizer (PTV) inlet, and the
resulting methyl mycocerosates, shown in Fig. 2, were then ana-
lyzed by GC–MS. The initial THM-GC–MS method development [14]
and its application to a batch of positive and negative real spu-
tum samples [15] were presented in our earlier publications, which
focused on the overall method performance without reporting and
discussing the particular results obtained in certain sputum sam-
ple extracts with a high level of matrix compounds. Blind analysis
of the PE extracts of 400+ sputum specimens [15], using our THM-
GC–MS method gave 64.9% sensitivity and 76.2% speciﬁcity, and
it was noted that other components of sputum, such as choles-
terol, may  hinder the analysis. The presence of matrix peaks in
the retention time region of the analytes and a high baseline ren-
dered difﬁcult the assignment of the target doublet peaks, when
a low target signal was hidden by abundant background peaks.
Derivatized matrix compounds build up in the inlet, which even-
tually leads to active sites and may  compromise subsequent runs.
This also impacted on the column life time, causing frequent col-
umn overloading and even column blockages, the capillary column
needed trimming and/or replacement. Both the PTV inlet and the
Fig. 2. Molecular structures of the target analytes resulted from the transesteriﬁca-
tion of the PDIM moieties (B)–(D) as shown in Fig. 1, via thermally assisted hydrolysis
and  methylation in the PTV inlet.
EIMS ionization source required cleaning on a regular basis, which
is not ideal for a routine method. It is therefore desirable to extract
PDIMs from the sputum sample, and to ﬁlter the extract in order to
purify and concentrate them prior to analysis.
In the present work, a proof of principle clean up method was
developed, aiming for a maximum recovery of PDIMs and minimum
collection of cholesterol from a stock solution of PDIMs and choles-
terol standards in PE. The lipid extraction from sputum samples
was performed with a combination of apolar petroleum ether (PE)
and an immiscible polar solvent (methanol), applying a modiﬁed
Dobson protocol [10]. Four PE extracts of positive sputum sam-
ples were selected that were previously [15] found to have high
amounts of cholesterol. These were then passed through different
solid phase extraction (SPE) materials, both commercial and molec-
ularly imprinted polymers (MIPs) cartridges. Molecular imprinting
is performed by producing a polymeric matrix, containing comple-
mentary residues, in the presence of the target molecule [16], in this
case cholesterol. After formation, the original template is removed,
leaving cavities that are complementary to the shape and chemi-
cal proﬁle of the template, only allowing speciﬁc recognition and
rebinding.
2. Experimental
2.1. Molecularly imprinted polymer synthesis
Methacrylic acid (MAA), ethyleneglycol dimethacrylate
(EGDMA) and azo-N,N′-diisobutyronitrile (AIBN); and all sol-
vents (HPLC grade) were purchased from Sigma Aldrich, (Dorset,
UK).
Cholesterol is a favoured template for imprinting studies and
has been imprinted by several different researchers [17–19]. A
generic MAA/EGDMA methodology was used as proof-of-principle,
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similar to that of Puoci et al. [17]. For the polymerization proce-
dure, the template (cholesterol), the monomers, cross-linker and
free-radical initiator AIBN were dissolved in the porogen chloro-
form in the ratio 1:4:20 with 125% of mixture to porogen ratio. An
amount of 25 mg of template was dissolved into 1.41 mL  of chloro-
form in a 4.5 mL  glass vial. To this solution, 21.9 L of methacrylic
acid (monomer) and 1.63 mL  of EGDMA (cross-linker) were added
and mixed using a vortex. 10 mg  of AIBN were added to this solu-
tion and mixed via vortex. Once all components had dissolved,
the solution was then sparged with nitrogen for 1 min  and the
vial sealed. Polymerization was carried out at 60 ◦C for 24 h, in a
dry oven. After polymerization, the tubes were then smashed and
the monolithic polymer obtained was ground with a mortar and
pestle and wet-sieved (methanol) through a series of mesh metal
sieve. Particle fractions of 63–38 m size were collected. Fine par-
ticles were removed by repeated sedimentation using acetonitrile.
Removal of the imprinted cholesterol from the imprinted parti-
cles was undertaken by a Soxhlet extraction with methanol–acetic
acid (9:1, v/v) for 48 h. Non-imprinted polymers (NIPs) were syn-
thesized and treated simultaneously under the same conditions
without the addition of the template. Empty 3 mL  polymeric SPE
cartridges were packed with 20 mg  of polymer, between two glass
ﬁbre frits (20 m porosity). This general method is adapted from
Zulﬁqar et al. [20].
2.2. Phthiocerol dimycocerosates (PDIMs) standard
The PDIMs standard consists of waxes extracted from freeze-
dried M.  tuberculosis strain C [21], using petroleum ether (PE) from
Fischer Scientiﬁc (Loughborough, UK) in a biphasic mixture with
aqueous methanol [10]. The main component of the PDIMs based
on phthiocerol A [22], was puriﬁed from the PE extract by prepara-
tive thin-layer chromatography [23]. The relative abundances of
the C29/C30 and C32 in the standard are not known, hence the
quantitative analyses in this study will be reported with respect
to the total amount of PDIMs present. Using petroleum ether (PE)
(60–80 ◦C, pesticide residue grade, Distol) from Fisher Scientiﬁc
(Loughborough, UK) as a solvent, a stock solution was  prepared,
containing 625 ng mL−1 of cholesterol (Acros) from Sigma–Aldrich
(Gillingham, UK) and 17.2 ng mL−1 of PDIMs standard.
Table 1
The combinations and concentrations of solvents tested for the optimization of
the  clean-up assay aiming to maximizing the recovery of PDIMs and the choles-
terol removal from a stock solution of standards in PE solvent, through commercial
Isolute-Fl (Florisil) SPE cartridges.
Washing
mix
Solvent Polarity
index
Boiling
temp. (◦C)
Solvents concentrations in the
washing mix  (%)
A DCM 3.1 39.9 30 40 50 60 100
Hexane 0 68.7 70 60 50 40 –
B Toluene 2.4 110.6 30 50 70 75 80 85
Heptane 0 98.4 70 50 30 25 20 15
2.3. Sputum samples
Sputum specimens were collected from TB patients and suspects
at Beatrice Road Infectious Diseases Hospital in Harare, Zimbabwe
[24]. Sputum samples were homogenized with glass beads and then
split into two: one sample was  used for smear microscopy and cul-
ture. The second aliquot of sputum was frozen until shipment to
London, where they were decontaminated and fully homogenized,
using the modiﬁed Petroff’s method [25]. In brief, 0.5 mL of the
sputum samples were homogenized with 0.5 mL of 4% methano-
lic NaOH, vortexed, incubated at room temperature for 20 min,
then neutralized with phosphate buffer, washed in sterile distilled
water, and centrifuged, resulting in a 1 mL  initial sputum deposit
that was heat killed (30 min  at 100 ◦C), then stored at −80 ◦C prior
to the apolar lipids extraction. Defrosted deposits were further
concentrated by centrifugation at 14,000 × g for 15 min. The super-
natant (800 L) was  discarded leaving behind a 0.2 mL deposit that
was subsequently submitted to the apolar lipid extraction.
2.4. Apolar lipid extraction
Using a modiﬁed method from Dobson [10], the apolar lipids
were extracted from 0.2 mL  of sputum deposits, by adding 1.8 mL
methanol and 1 mL  petroleum ether (60–80 ◦C), mixed on a tube
rotator for 15 min, then centrifuged at 1200 × g for 1 min. The upper
PE layer, containing the apolar lipids, was  removed and stored at
4 ◦C prior to the THM-GC–MS analysis.
Fig. 3. Flow chart from sputum deposits to the THM-GC–MS analysis of the PE extracts. Top: the sample processing and analysis method without clean-up procedure; middle:
protocol for the PE extract clean-up through commercial Isolute-FL SPE cartridges; bottom: ﬁltering of the PE extract through developed MIPs materials.
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2.5. Sample clean up
Firstly, aliquots of 50 L of the stock solution of PDIMs and
cholesterol standards mix  in PE were placed into different com-
mercial SPE cartridges Isolute-Florisil from Biotage UK (Hengoed,
UK), then washed in 4 mL  of the solvent mixtures (A) or (B)
described below. In order to identify the solvent mix  with the
optimum polarity to wash out the pthiocerol dimycocerosates,
while leaving the cholesterol adsorbed on the SPE cartridge, the
following solvent combinations were used: (A) dichloromethane
and hexane (DCM + H), and (B) heptane with toluene (Hp + T)
with the relative concentrations as summarized in Table 1. All
the solvents were pesticide residue grade, Distol from Fisher
Scientiﬁc (Loughborough, UK). Finally, the 4 mL  of solvents mix
eluted through the SPE cartridges were reconstituted in 50 L
petroleum ether, and were then submitted to the THM-GC–MS
analysis. Two positive sputum specimens were identiﬁed that
had large cholesterol peaks in the original PE extracts. Aliquots
of 50 L from these PE extracts were loaded onto the SPE car-
tridges, and then the solvent mix  that had been selected for the
standards clean-up was further tested on the PE sputum extracts
selected.
Secondly, 500 L aliquots of the stock solution of PDIMs and
cholesterol standards in PE were washed through molecular
imprinted polymers (MIPs) SPE cartridges developed at The Open
University, and 50 L of the ﬁrst eluent collected (roughly 350 L)
were submitted to the THM-GC–MS analysis. The clean-up method
was then tested on two other positive sputum samples, by ﬁltering
500 L of each PE sputum extract through a MIPs cartridge.
2.6. Equipment
An Agilent GC–MS system was used, consisting of a 7890A
gas chromatograph equipped with a DB-5 MS  capillary column
(15 m × 0.25 mm × 0.25 m)  coupled to a 5975C quadrupole mass
spectrometer (MS), with the electron impact (EI) ionization source
set at 70 eV and 35 A emission current. The column dimensions in
our method were consistent with the end-user operational require-
ments for its potential use as a diagnostic test in the ﬁeld. An
autosampler PAL-CTC provided with a LINEX liner exchanger was
used in conjunction with an Optic3 programmable temperature
vaporization (PTV) inlet, to perform the online derivatization of
the analytes. Both the autosampler and the inlet were provided
by GL-Scientiﬁc (former ATAS-GL International) (Eindhoven, The
Netherlands).
2.7. Thermochemolysis
Fifty microlitre aliquots (i) of the initial stock solution of choles-
terol (625 ng mL−1) and PDIMs (17.2 ng mL−1) in PE solvent; (ii) of
the unﬁltered PE sputum extracts; and (iii) of each eluent through
the SPE cartridges were manually applied to a quartz wool plug,
inside separate injector liners. The samples were dried ofﬂine, on
a hot plate at 60–70 ◦C for 10 min, and then placed on the Linex
autosampler tray. The liners were then loaded into the Optic3 PTV
inlet, where the thermally assisted hydrolysis and methylation
(THM) of the lipids was performed in helium at 380 ◦C, following
the automated injection of 40 L methanolic tetramethylammo-
nium hydroxide TMAH. Methanolic TMAH (25%, Acros), purchased
from Sigma–Aldrich (Gillingham, UK) was diluted to 12.5% in MeOH
(pesticide residue grade, Distol) from Fisher Scientiﬁc (Loughbor-
ough, UK) and was used for the online derivatization of lipids by
THM.
Fig. 4. (a) Typical ion chromatograms of the fragment ions at m/z 101 (top trace)
and  m/z 88 (lower trace) obtained in SIM mode for 140 pg total PDIMs submitted
to  thermochemolysis with 40 L methanolic TMAH (12.5%). (b)–(d) mass spectra of
C29, C30, and C32 methyl mycocerosates, obtained in full scan mode for 4.5 ng total
PDIMs under electron impact at 70 eV electron energy.
2.8. GC–MS analysis
The methyl mycocerosates, resulting from the transesteriﬁca-
tion of PDIMs via the thermochemolysis process, were separated
along the capillary column with a temperature programme of 50 ◦C
(8 min) to 350 ◦C (1 min) at 30 ◦C/min, and at a carrier gas ﬂow rate
of 1.1 mL  of helium per min.
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Fig. 5. Examples of the GC–MS traces in full scan (left) and SIM (right) for sputum samples with high cholesterol content: (a) a negative sputum (N1); and (b) a positive
sputum  (P1) (* the cholesterol derivative peak in full scan).
The mass spectrometer was operated to alternatingly collect
fragment ions in full scan and selected ion monitoring (SIM) modes.
Thus, for each analysis run, the instrument generates two  chro-
matographic traces: the full mass scan, and the SIM trace. The
target compounds were detected by collecting the fragment ions
m/z 88, 101 (methyl mycocerosates C29/C30, and C32) in SIM mode,
and the fragment ion m/z 368 extracted from full scan data, for
the methyl ether of cholesterol. Considering that the PDIMs are
expected to be present at trace levels, their speciﬁc ions were col-
lected in SIM mode, thus reducing the instrumental noise by a
factor of 10, whereas the much more abundant cholesterol peak
was analyzed in the full scan simultaneous mode, thus keeping
the number of diagnostic ions in SIM to the minimum required
for the biomarker analytes. Quantitation of both the mycocerosic
acid methyl esters, and the cholesterol methylated derivative was
performed using the integration facility in Agilent ChemStation, by
manually measuring the areas of the above named peaks in the SIM
chromatogram for m/z 101, and in full scan for the m/z  368 fragment
ions, respectively.
3. Results and discussion
Fig. 3 shows a summary ﬂowchart of the sputum samples clean
up procedure as developed and described in Section 2. In essence
a multi-step protocol was developed aiming to ensure the cleanest
sample possible for injection onto the GC column.
3.1. Initial methodology
The top line of Fig. 3 shows the current methodologies as
described in our prior publications [14,15]. The ion chromatograms
for m/z 101 and m/z 88 obtained for the methyl derivatives of
140 pg of PDIMs standard are shown in Fig. 4a. The doublet
peaks can be observed, which are characteristic to the coeluting
diastereoisomers of methyl mycocerosates C29 and C30, and to the
diastereoisomers of C32, respectively, as discussed in our earlier
publications [14,15]. The mass spectra of C29, C30, and C32 are shown
in Fig. 4b–d. Fig. 5 shows some examples of the GC–MS traces in full
scan and in SIM, respectively, for sputum samples with high choles-
terol content: (a) a negative sputum, and (b) a positive sputum
sample extract that saturates the column with both methylated
and underivatized cholesterol, identiﬁed in the NIST library of mass
spectra (98% match).
Given the column overloading by abundant sputum matrix
background, a pre-injection clean-up protocol was necessary. Two
methods were studied. The ﬁrst was  based around a commercial
material (Isolute-FL), a synthetic magnesium silicate that is often
used for commercial clean-up protocols. The second was to use
a developed MIP  material, designed to absorb cholesterol. As dis-
cussed above, cholesterol is a common model target for imprinting
and a number of papers have developed methodologies. Here we
selected an acidic based polymer, similar to the work of Puoci
et al. [17], which had demonstrated the ability to selectively bind
the target molecule. Given the nature of the PDIM fragments, we
expected very little interaction with the polymer, based on the rela-
tive charges; however, some non-speciﬁc interactions of the PDIMs
may  also occur with the MIP  material.
3.2. Isolute-FL (Florisil) extraction
Fig. 6a shows the percentage recovery of PDIMs and of choles-
terol, using solvent mix  A of dicholoromethane (DCM) and hexane
(H), with DCM concentration ranging between 0 and 100%. The
study aimed to identify the optimum solvent mix  polarity relative
to that of the SPE packing, to preferentially extract the PDIMs tar-
get analytes, while leaving behind most of the cholesterol. Table 1
summarizes the two  solvent combinations that we studied, and
the various concentrations. In this ﬁrst attempt, the DCM:hexane
mix  of solvents at 40% DCM concentration, provided a consistent
recovery of 76.4% for PDIMs with only 6.3% for cholesterol. While
in temperate and cold climates this solvent mix  can be used for
clean-up, for the method to be ﬁeld deployable in countries with
high incidence of tuberculosis, hence in tropical countries, we  fur-
ther aimed at replacing the highly volatile DCM (b.p. = 39.9 ◦C) in
140 S.C. Nicoara et al. / J. Chromatogr. B 986–987 (2015) 135–142
Fig. 6. Recovery of PDIMs and of cholesterol from a standards stock solution in PE, following clean up through commercial Isolute-FL SPE cartridges, washed with: (a) washing
mix  A (dichloromethane:hexane); and (b) washing mix  B (toluene:heptane).
a different solvent mix  of higher boiling temperatures and also of
appropriate polarity.
After testing various less volatile solvents combinations, the pre-
liminary results lead us to select the solvent mix  B of heptane (Hp)
and toluene (To). Fig. 6b presents the results obtained after sample
clean up through Isolute-FL cartridges with combinations of To and
Hp. The ideal proportion of these solvents was found to be at 70%
toluene, having provided an average recovery of 80.1% for PDIMs
and of only 2.05% for cholesterol, from 50 L of the stock PE solu-
tion of standards. When tested on two PE sputum extracts passed
through commercial Isolute-FL cartridges, this solvent combina-
tion resulted in cleaner chromatograms, as shown in Fig. 7, with
recoveries between 38.3 and 68.7% for PDIMs and only 7.8–37.6%
for cholesterol. The poorer efﬁciency of the clean-up with solvent
mix  B in sputum sample extracts can be due to the matrix com-
plexity and needs to be further investigated. While solvent mix  A
containing DCM lead to some better results (not shown here) in cer-
tain sputum sample extracts, we aimed for a mix  of solvents with
higher boiling temperatures, that can be used in countries with a
high incidence of tuberculosis, and also with warmer climate.
Fig. 7. The result of sample clean-up through Isolute-FL commercial SPE cartridges, using a concentration of 70% toluene in a mix  with heptane. (a) Comparing the full scan
plots  of ﬁltered (black), and non-ﬁltered (grey) PE extract of two  positive sputum samples with high cholesterol (* = cholesterol derivative peak). (b) Recovery of PDIMs and
of  cholesterol from two positive sputum samples extracts, washed via Isolute-FL SPE cartridge, with 70% toluene in a mix  with heptane.
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Fig. 8. The result of PE sputum sample extracts ﬁltered through MIPs cartridges: (a) comparing the plots of the fragment ion m/z 101 extracted from SIM scans for ﬁltered
(black) and non-ﬁltered (grey) PE extracts of two  positive sputum samples (* = cholesterol derivative peak). (b) Recovery of PDIMs and of cholesterol from two positive
sputum  PE extracts, ﬁltered through MIPs SPE cartridges.
3.3. Molecularly imprinted polymer clean-up
Performing the sample clean-up through MIP  cartridges as
described in the Experimental section and schematically presented
in Fig. 3, is signiﬁcantly simpler than with the commercial SPE,
involving less manipulation of solvents and vials. The THM-GC–MS
analysis of 50 L aliquots of the 350 L eluent collected from 500 L
standards solution ﬁltered through the MIPs cartridge generated
cleaner chromatograms. In the standard stock solution, the clean-
up resulted in 64.1–70.6% recovery of PDIMs, and 1.7–6.5% recovery
of cholesterol. Fig. 8 shows an example of overlaying the GC–MS
traces obtained from two positive sputum sample extracts, by
thermochemolysis of 50 L aliquots, before and after the clean
up through the MIPs cartridges. The quantitative results indicate
that a signiﬁcant amount of the cholesterol background has been
removed through the ﬁltration of the sputum extracts, with recov-
eries between 37.5 and 69.7% for PDIMs, and of 8.9–14.5% for
cholesterol. Based on the above, we believe that further optimiza-
tion of MIPs cartridges is needed that could ensure more efﬁcient
ﬁltration of PDIMs and removal of cholesterol via a procedure that
involves less manipulation of the sample extracts.
These results are very promising for the potential use of SPE
clean-up of the PE extracts from real sputum samples, prior to
their THM-GC–MS analysis. The chromatograms present reduced
matrix peaks, thus improving the conditions to correctly assign the
biomarkers signal. One big advantage of using SPE sample clean-
up is that this will lead to a lower amount of matrix background
introduced in the system, less biologic material deposited on the
inlet wall, a reduced risk of column overloading and blockage, and
hence enabling a more robust analytical protocol. This allows the
analysis of a greater number of sputum samples extracts with a
reduced frequency of instrumental interventions for cleaning the
inlet and the mass spectrometer ion source, and for column trim-
ming. The present proof of principle assay can further be developed
in a systematic study to evaluate the optimum SPE clean-up proce-
dure for an efﬁcient removal of the biological matrix compounds,
in order to provide a high sensitivity and selectivity of a more
robust and reproducible THM-GC–MS method for the detection of
M. tuberculosis in sputum samples.
4. Conclusions
In order to ease the identiﬁcation of the target compound
biomarkers for tuberculosis in sputum, a proof of principle study
was performed of some sample clean-up methods by commercial
and MIPs solid phase extraction cartridges, aiming to selectively
eliminate the major matrix compounds from the PE sputum
extracts.
When used with the proper solvent combinations, the Isolute-
Florisil SPE commercial cartridges can remove a high amount of
the abundant cholesterol from the sputum extracts, while still
recovering more than 70% of the total PDIMs biomarkers present.
Though, sample manipulation is more complex and requires rel-
atively longer time than the ﬁltering through MIPs. The MIPs
cartridges are relatively easier to use, and the results obtained with
standards solution show the potential for selective clean-up of spu-
tum sample extracts.
Both clean-up methods demonstrated the potential to remove
the cholesterol from the matrix background present in the PE
sputum extracts, without signiﬁcant loss of the biomarker target
analytes. The next step, currently under investigation, is to test
this clean-up method to a greater number of sputum samples and
apply clinically relevant statistics to the study, to further assess the
method performance for the whole sample processing, as promised
by the results obtained in the developed methods presented.
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